TY - JOUR
T1 - Utilization of Alcohol Treatment Among HIV-Positive Women with Hazardous Drinking
AU - Hu, Xingdi
AU - Harman, Jeffrey
AU - Winterstein, Almut G.
AU - Zhong, Yue
AU - Wheeler, Amber L.
AU - Taylor, Tonya N.
AU - Plankey, Michael
AU - Rubtsova, Anna
AU - Cropsey, Karen
AU - Cohen, Mardge H.
AU - Adimora, Adaora A.
AU - Milam, Joel
AU - Adedimeji, Adebola
AU - Cook, Robert L.
N1 - Funding Information:
This work was supported by a grant from the National Institutes of Health ( U01-AA020797 ). Data in this manuscript were collected by the Women's Interagency HIV Study (WIHS). The contents of this publication are solely the responsibility of the authors and do not represent the official views of the National Institutes of Health (NIH). WIHS (Principal Investigators): UAB-MS WIHS (Michael Saag, Mirjam-Colette Kempf, and Deborah Konkle-Parker), U01-AI-103401; Atlanta WIHS (Ighovwerha Ofotokun and Gina Wingood), U01-AI-103408; Bronx WIHS (Kathryn Anastos), U01-AI-035004; Brooklyn WIHS (Howard Minkoff and Deborah Gustafson), U01-AI-031834; Chicago WIHS (Mardge Cohen), U01-AI-034993; Metropolitan Washington WIHS (Mary Young), U01-AI-034994; Miami WIHS (Margaret Fischl and Lisa Metsch), U01-AI-103397; UNC WIHS (Adaora Adimora), U01-AI-103390; Connie Wofsy Women's HIV Study, Northern California (Ruth Greenblatt, Bradley Aouizerat, and Phyllis Tien), U01-AI-034989; WIHS Data Management and Analysis Center (Stephen Gange and Elizabeth Golub), U01-AI-042590; Southern California WIHS (Alexandra Levine and Marek Nowicki), U01-HD-032632 (WIHS I–WIHS IV). The WIHS is funded primarily by the National Institute of Allergy and Infectious Diseases (NIAID) , with additional co-funding from the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) , the National Cancer Institute (NCI) , the National Institute on Drug Abuse (NIDA) , and the National Institute on Mental Health (NIMH) . Targeted supplemental funding for specific projects is also provided by the National Institute of Dental and Craniofacial Research (NIDCR) , the National Institute on Alcohol Abuse and Alcoholism (NIAAA) , the National Institute on Deafness and other Communication Disorders (NIDCD) , and the NIH Office of Research on Women's Health . WIHS data collection is also supported by UL1-TR000004 ( UCSF CTSA ) and UL1-TR000454 ( Atlanta CTSA ).
Publisher Copyright:
© 2016 Elsevier Inc.
PY - 2016/5/1
Y1 - 2016/5/1
N2 - Hazardous alcohol consumption has been frequently reported among women with HIV infection and is associated with a variety of negative health consequences. Treatments to reduce alcohol use may bring in health benefits. However, little is known regarding the utilization of alcohol treatment services among HIV. + women with hazardous drinking. Using data from the Women's Interagency HIV Study (WIHS), this study assessed utilization of any alcohol treatment in the past 6 months and performed multivariable logistic regression to determine correlates of receipt of any alcohol treatment. Among 474 HIV. + women reporting recent hazardous drinking, less than one in five (19%) reported recent utilization of any alcohol treatment. Alcoholics Anonymous (AA) was the most commonly reported (12.9%), followed by inpatient detoxification (9.9%) and outpatient alcohol treatment program (7.0%). Half (51%) receiving any alcohol treatment reported utilization of multiple treatments. Multivariable analyses found alcohol treatment was more often utilized by those who had social support (odds ratio [OR] = 1.68, 95% confidence interval [CI] = 1.00 to 2.83), fewer economic resources (income ≤$12,000 vs. >$12,000, OR = 3.10, 95% CI = 1.53 to 6.27), higher levels of drinking (16-35 drinks/week vs. 12-15 drinks/week, OR = 3.02, 95% CI = 1.47 to 6.21; 36. + drinks/week vs. 12-15 drinks/week, OR = 4.41, 95% CI = 2.03 to 9.59), and those who reported any illicit drug use (OR = 2.77, 95% CI = 1.44 to 5.34). More efforts are needed to enhance the utilization of alcohol treatment. Our findings highlight the unique profile of those who utilized alcohol treatment. Such information is vital to improve treatment delivery to address unmet need in this particular population.
AB - Hazardous alcohol consumption has been frequently reported among women with HIV infection and is associated with a variety of negative health consequences. Treatments to reduce alcohol use may bring in health benefits. However, little is known regarding the utilization of alcohol treatment services among HIV. + women with hazardous drinking. Using data from the Women's Interagency HIV Study (WIHS), this study assessed utilization of any alcohol treatment in the past 6 months and performed multivariable logistic regression to determine correlates of receipt of any alcohol treatment. Among 474 HIV. + women reporting recent hazardous drinking, less than one in five (19%) reported recent utilization of any alcohol treatment. Alcoholics Anonymous (AA) was the most commonly reported (12.9%), followed by inpatient detoxification (9.9%) and outpatient alcohol treatment program (7.0%). Half (51%) receiving any alcohol treatment reported utilization of multiple treatments. Multivariable analyses found alcohol treatment was more often utilized by those who had social support (odds ratio [OR] = 1.68, 95% confidence interval [CI] = 1.00 to 2.83), fewer economic resources (income ≤$12,000 vs. >$12,000, OR = 3.10, 95% CI = 1.53 to 6.27), higher levels of drinking (16-35 drinks/week vs. 12-15 drinks/week, OR = 3.02, 95% CI = 1.47 to 6.21; 36. + drinks/week vs. 12-15 drinks/week, OR = 4.41, 95% CI = 2.03 to 9.59), and those who reported any illicit drug use (OR = 2.77, 95% CI = 1.44 to 5.34). More efforts are needed to enhance the utilization of alcohol treatment. Our findings highlight the unique profile of those who utilized alcohol treatment. Such information is vital to improve treatment delivery to address unmet need in this particular population.
KW - Alcohol treatment
KW - Hazardous drinking
KW - Social support
KW - Utilization
KW - Women with HIV
UR - http://www.scopus.com/inward/record.url?scp=84959487195&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84959487195&partnerID=8YFLogxK
U2 - 10.1016/j.jsat.2016.01.011
DO - 10.1016/j.jsat.2016.01.011
M3 - Article
C2 - 26961420
AN - SCOPUS:84959487195
SN - 0740-5472
VL - 64
SP - 55
EP - 61
JO - Journal of Substance Abuse Treatment
JF - Journal of Substance Abuse Treatment
ER -
